High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 9, Pages 2129
Publisher
MDPI AG
Online
2020-09-21
DOI
10.3390/cells9092129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo
- (2020) Alexander Schulte et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
- (2020) Claudia Koch et al. EMBO Molecular Medicine
- Circulating Tumor Cells: Come Together, Right Now, Over Metastasis
- (2019) Paulo Rodrigues et al. Cancer Discovery
- Liquid biopsy and minimal residual disease — latest advances and implications for cure
- (2019) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
- (2019) Zujun Que et al. Cancer Cell International
- Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer
- (2019) Luis Enrique Cortés-Hernández et al. MOLECULAR ASPECTS OF MEDICINE
- Distinct functions of AKT isoforms in breast cancer: a comprehensive review
- (2019) Nico Hinz et al. Cell Communication and Signaling
- Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population‐based analysis
- (2019) Jiwei Wang et al. Cancer Medicine
- Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
- (2018) Katharina E. Effenberger et al. CLINICAL CANCER RESEARCH
- The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis
- (2018) Yi Tan et al. CURRENT PROBLEMS IN CANCER
- Targeting the PI3K pathway in cancer: are we making headway?
- (2018) Filip Janku et al. Nature Reviews Clinical Oncology
- Expression of factors and key components associated with the PI3K signaling pathway in colon cancer
- (2018) Hua Chen et al. Oncology Letters
- Circulating tumor cells in clinical research and monitoring patients with colorectal cancer
- (2018) Claudia Burz et al. Oncotarget
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Analysis of single circulating tumor cells (CTCs) to identify resistance mutations to ALK-inhibitors in both ALK-gene and bypass oncogenic pathways.
- (2018) Emma Pailler et al. JOURNAL OF CLINICAL ONCOLOGY
- Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes
- (2018) Alexandra Soler et al. Scientific Reports
- iCTC drug resistance (CDR) Testing ex vivo for evaluation of available therapies to treat patients with epithelial ovarian cancer
- (2017) Michael L. Pearl et al. GYNECOLOGIC ONCOLOGY
- Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis
- (2017) E Agarwal et al. ONCOGENE
- AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins
- (2017) Marina Riggio et al. Scientific Reports
- Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair
- (2016) Catherine Alix-Panabières et al. CLINICAL CHEMISTRY
- MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer
- (2016) Emne Ali Abdallah et al. INTERNATIONAL JOURNAL OF CANCER
- Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells
- (2016) Sara Häggblad Sahlberg et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epithelial-mesenchymal plasticity in circulating tumor cells
- (2016) Catherine Alix-Panabières et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4
- (2016) Astrid Grottke et al. PLoS One
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- Akt isoform specific effects in ovarian cancer progression
- (2016) Nicolle M. Linnerth-Petrik et al. Oncotarget
- Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
- (2015) Matthias Reeh et al. ANNALS OF SURGERY
- Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells
- (2015) L. Cayrefourcq et al. CANCER RESEARCH
- Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
- (2015) Lydia G. M. van der Geest et al. CLINICAL & EXPERIMENTAL METASTASIS
- Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
- (2015) Florian Ewald et al. Journal of Cancer
- mTOR pathway in colorectal cancer: an update
- (2015) Maria Giovanna Francipane et al. Oncotarget
- Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors
- (2014) Florian Ewald et al. INVESTIGATIONAL NEW DRUGS
- Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
- (2014) R. Dienstmann et al. MOLECULAR CANCER THERAPEUTICS
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
- (2014) M. Yu et al. SCIENCE
- Targeting PI3K/Akt/mTOR Signaling in Cancer
- (2014) Camillo Porta et al. Frontiers in Oncology
- Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens
- (2013) K. Ng et al. CLINICAL CANCER RESEARCH
- Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
- (2013) Florian Ewald et al. INTERNATIONAL JOURNAL OF CANCER
- Epithelial-to-Mesenchymal Transition Rewires the Molecular Path to PI3K-Dependent Proliferation
- (2013) M. B. Salt et al. Cancer Discovery
- Compartmental Differences of Circulating Tumor Cells in Colorectal Cancer
- (2012) Nuh N. Rahbari et al. ANNALS OF SURGICAL ONCOLOGY
- Circulating Tumor Cells: Liquid Biopsy of Cancer
- (2012) C. Alix-Panabieres et al. CLINICAL CHEMISTRY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells
- (2011) Nicole Grabinski et al. CELLULAR SIGNALLING
- Ablation of Akt2 Induces Autophagy through Cell Cycle Arrest, the Downregulation of p70S6K, and the Deregulation of Mitochondria in MDA-MB231 Cells
- (2011) Stacey A. Santi et al. PLoS One
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study
- (2010) Noemi Garrigós et al. Clinical & Translational Oncology
- PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
- (2010) P. Wu et al. CURRENT MEDICINAL CHEMISTRY
- Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
- (2010) Sara M. Johnson et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancing Mammalian Target of Rapamycin (mTOR)-Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation
- (2008) X. Wang et al. CANCER RESEARCH
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
- (2008) Steven J. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Aldehyde Dehydrogenase as a Marker for Stem Cells
- (2008) Jan Moreb Current Stem Cell Research & Therapy
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now